Stephanie Turner

FinCEN Finalizes Rule Implementing Beneficial Ownership Reporting Requirements

"Do More And Move Faster" – The DOJ Announces Significant Policy Changes To Prioritize Corporate Criminal Prosecutions

FDA Issues Draft Guidance To Clarify Referencing Of The Terms "Device" And "Counterfeit Device"

FDA Publishes Guidance On The Enhanced System Under The DSCSA Going Into Effect On November 27, 2023

FDA Interprets Terms Used In Definitions Of Suspect And Illegitimate Product Under The DSCSA

FDA Publishes Guidance On The Identification And Notification Of Suspect Products As Part Of The Implementation Of The Drug Supply Chain Security Act

FDA Publishes Guidance On Remote Interactive Evaluations For Oversight Of Drug Manufacturing And Bioresearch Monitoring Facilities During The COVID-19 Public Health Emergency